No connection

Search Results

ASST

BEARISH
$0.87 Live
Strive Asset Management, LLC · NASDAQ
Target $1.5 (+72.3%)
$0.39 52W Range $13.42

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
$1.09B
P/E
N/A
ROE
N/A
Profit margin
N/A
Debt/Equity
0.0
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
The company exhibits weak financial health with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score to confirm solvency, raising uncertainty. Despite a strong revenue growth of 56.80% YoY and a low Price/Book of 0.74 suggesting possible value, extreme negative operating margins (-3064.29%) and a sky-high Price/Sales ratio of 197.00 signal severe profitability and valuation concerns. The stock has lost over 95% of its value in the past five years, with a current technical trend scoring 0/100, reflecting deep investor skepticism. While the balance sheet shows no debt and high liquidity ratios, these positives are overshadowed by absent profitability, lack of earnings, and minimal analyst coverage.

Key Strengths

Strong year-over-year revenue growth of 56.80%
Exceptionally high current ratio (11.97) and quick ratio (11.43), indicating strong short-term liquidity
Zero debt (Debt/Equity: 0.00), suggesting conservative capital structure
Low Price/Book ratio of 0.74, potentially indicating undervaluation on book value basis
Analyst recommendation is 'buy' despite limited coverage

Key Risks

Piotroski F-Score of 4/9 indicates weak financial health and limited operational strength
Operating margin of -3064.29% reflects catastrophic unprofitability
Price/Sales ratio of 197.00 is extremely high, suggesting severe overvaluation relative to sales
No Graham Number or Intrinsic Value available, indicating lack of reliable earnings or book value foundation
Stock down 95.1% over 3Y and 5Y, with technical trend at 0/100, signaling persistent bearish momentum

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
24
Weak
Value
20
Future
55
Past
15
Health
30
Dividend
0
AI Verdict
Highly speculative with severe financial weaknesses despite revenue growth and clean balance sheet.
Key drivers: Negative operating margin, Extremely high Price/Sales ratio, Low Piotroski F-Score, Lack of profitability metrics, Catastrophic historical price performance
Confidence
80%
Value
20/100

Ref P/E, PEG, Graham Number

Positives
  • Price/Book of 0.74 is below 1, suggesting possible asset-based value
Watchpoints
  • Price/Sales of 197.00 is extremely elevated
  • Forward P/E of -29.02 indicates negative earnings
  • No Graham Number due to lack of earnings or book value reliability
Future
55/100

Ref Growth rates

Positives
  • Revenue Growth (YoY) of 56.80% is strong
  • Analyst target price of $1.50 implies 72% upside
Watchpoints
  • No earnings growth data available
  • Forward P/E negative, indicating no near-term profit expectations
Past
15/100

Ref Historical trends

Positives
  • Recent 1-month price change of +1.0% shows minor stabilization
Watchpoints
  • 5Y and 3Y price change of -95.1% indicates massive value destruction
  • 6M change of -78.9% shows ongoing collapse
  • 1W change of -8.1% reflects continued selling pressure
Health
30/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Piotroski F-Score of 4/9 indicates minimal financial stability
  • Current Ratio of 11.97 and Quick Ratio of 11.43 show strong liquidity
Watchpoints
  • Piotroski score below 5 signals weak financial health
  • No Altman Z-Score available to assess bankruptcy risk
  • Operating and net margins are deeply negative
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • Dividend Strength of 0/100
  • No dividend yield or payout history
  • No indication of dividend policy

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$0.87
Analyst Target
$1.5
Upside/Downside
+72.3%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ASST and closest competitors.

Updated 2026-01-23
ASS
Strive Asset Management, LLC
Primary
5Y
-95.1%
3Y
-95.1%
1Y
-17.8%
6M
-78.9%
1M
+1.0%
1W
-8.1%
HGT
Hagerty, Inc.
Peer
5Y
+9.9%
3Y
+7.1%
1Y
+21.8%
6M
-4.1%
1M
+3.2%
1W
-1.3%
GSB
Goldman Sachs BDC, Inc.
Peer
5Y
-6.4%
3Y
+7.1%
1Y
+5.5%
6M
+4.0%
1M
+11.5%
1W
-1.0%
OCF
OceanFirst Financial Corp.
Peer
5Y
+0.4%
3Y
+24.9%
1Y
+28.5%
6M
+5.6%
1M
+6.8%
1W
+0.5%
MFI
MidCap Financial Investment Corporation
Peer
5Y
+50.0%
3Y
+48.5%
1Y
+19.2%
6M
+7.2%
1M
+14.0%
1W
+2.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
-29.02
PEG Ratio
N/A
P/B Ratio
0.74
P/S Ratio
197.0
EV/Revenue
109.65
EV/EBITDA
-10.0
Market Cap
$1.09B

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin -3064.29%
Gross Margin N/A
ROE N/A
ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth +56.8%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.0
Low debt
Current Ratio
11.97
Strong
Quick Ratio
11.43
Excellent
Cash/Share
$0.13

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-09
$N/A

Financial Services Sector Comparison

Comparing ASST against 820 companies in the Financial Services sector (141 bullish, 351 neutral, 328 bearish)
Debt to Equity
0.0
This Stock
vs
1.36
Sector Avg
-99.7% (Less Debt)
Revenue Growth
56.8%
This Stock
vs
35.27%
Sector Avg
+61.1% (Fast Growth)
Current Ratio
11.97
This Stock
vs
3.18
Sector Avg
+276.4% (Stronger)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

PHAM BENJAMIN B.
Chief Financial Officer
Option Exercise
2026-01-16
212,930 shares · $201,879
SEMLER ERIC
Director
Stock Award
2026-01-16
15,032,162 shares
COLE MATTHEW RYAN
Chief Executive Officer
Buy
2026-01-13
500,000 shares · $459,350
COLE MATTHEW RYAN
Chief Executive Officer
Buy
2025-12-15
515,195 shares · $415,999
BEIRNE BRIAN LOGAN
Officer and Director
Option Exercise
2025-10-01
87,903 shares · $220,637
PHAM BENJAMIN B.
Chief Financial Officer
Option Exercise
2025-10-01
212,930 shares · $534,454
COLE MATTHEW RYAN
Chief Executive Officer
Option Exercise
2025-09-12
18,459,504 shares · $156,721,189
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
1 analysts
Maxim Group
2025-12-10
init
Buy

Past News Coverage

Recent headlines mentioning ASST from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile